Biofrontera Inc (BFRI NASDAQ) stock market data APIs
$1.0157
0.1(9.8%)
as of May 12, 2026
Try our APIs with
free plan!
Biofrontera Inc Financial Data Overview
Price chart is built with
Anychart
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Prev. Close
1.0157
Open
1.1199
High
1.1216
Low
0.9888
52 wk Range
0.536-1.19
Market Cap
11 647 K
Shares Outstanding
12 008 K
Revenue
41 705 K
EPS
0.4981
Beta
0.911
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Biofrontera Inc data using free add-ons & libraries
Get Biofrontera Inc Fundamental Data
Biofrontera Inc Fundamental data includes:
- Net Revenue: 41 705 K
- EBITDA: -11 210 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-19
- EPS/Forecast: 0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Biofrontera Inc News
New
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercializ...
Biofrontera Inc. Q4 2025 Earnings Call Summary
Biofrontera Inc. Q4 2025 Earnings Call Summary - Moby Strategic Pivot and Commercial Execution Achieved record annual revenue of $41.7 million, driven by a 10% increase in Ameluz unit volumes and re...
Biofrontera (BFRI) Q4 2025 Earnings Transcript
Image source: The Motley Fool. DATE Thursday, March 19, 2026 at 10 a.m. ET CALL PARTICIPANTS Chief Executive Officer, Chairman, and Founder — Hermann Lubbert Chief Commercial Officer — George ...
Biofrontera (BFRI) Q4 2025 Earnings Transcript
Image source: The Motley Fool. DATE Thursday, March 19, 2026 at 10 a.m. ET CALL PARTICIPANTS Chief Executive Officer, Chairman, and Founder — Hermann LubbertChief Commercial Officer — George J...
Get Biofrontera Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
